6505--Notice of Intent to Sole Source F-18 Piflufolastat (Pylarify for the George E. Wahlen VA Medical Center in Salt Lake City, Utah.
| Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Jan 27, 2026 |
| Due Date: | Feb 4, 2026 |
| Solicitation No: | 36C25926Q0213 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
Follow
Active
Contract Opportunity
Notice ID
36C25926Q0213
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
NETWORK CONTRACT OFFICE 19 (36C259)
General Information
Classification
Description
Contact Information
History
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Jan 27, 2026 02:16 pm MST
- Original Response Date: Feb 04, 2026 03:00 pm MST
- Inactive Policy: Manual
- Original Inactive Date: Feb 19, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6505 - DRUGS AND BIOLOGICALS
-
NAICS Code:
- 325412 - Pharmaceutical Preparation Manufacturing
-
Place of Performance:
INTENT TO SOLE SOURCE
THIS IS NOT A SOLICITATION OR REQUEST FOR OFFERS. NO SOLICITATION PACKAGE IS AVAILABLE NOR WILL TELEPHONE REQUESTS BE HONORED. NO SOLICITATION WILL BE POSTED TO CONTRACT OPPORTUNITIES.
PROCUREMENT TITLE: Pylarify Radiopharmaceuticals
INTENT TO AWARD: The Department of Veterans Affairs (NCO 19), 6162 S. Willow Drive, Greenwood Village, CO 80111, intends to award one (1) task order on a sole source basis, to Progenics Pharmaceuticals, Inc., for PYLARIFY® (piflufolastat F 18) Injections.
BACKGROUND AND DESCRIPTION: This procurement is for the continued providing of unit dose syringes of F-18 Piflufolastat (Pylarify) for positron emitting tomography (PET) imaging as ordered by the Nuclear Medicine Department.
Pylarify is a radiopharmaceutical, or medicinal radio-compound, and contains radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents to diagnose specific pathologies, such as cancer, osteomyelitis, cardiac ischemia, and infection.
NAICS: 325412 Pharmaceutical Preparation Manufacturing, $34 Million
PSC: 6505 Drugs and Biologicals
AUTHORITY: This procurement will be issued under the authority of FAR Part 8 Required Sources of Supplies and Services. A determination by the Government not to compete this proposed award upon response to this notice is solely within the discretion of the Contracting Officer.
INTERESTED PARTIES: THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement as described in the attached Statement of Work no later than 3:00 PM Mountain Standard Time, Wednesday, February 4th, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to heather.chase2@va.gov.
A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice.
ATTACHED: Statement of Work
THIS IS NOT A SOLICITATION OR REQUEST FOR OFFERS. NO SOLICITATION PACKAGE IS AVAILABLE NOR WILL TELEPHONE REQUESTS BE HONORED. NO SOLICITATION WILL BE POSTED TO CONTRACT OPPORTUNITIES.
PROCUREMENT TITLE: Pylarify Radiopharmaceuticals
INTENT TO AWARD: The Department of Veterans Affairs (NCO 19), 6162 S. Willow Drive, Greenwood Village, CO 80111, intends to award one (1) task order on a sole source basis, to Progenics Pharmaceuticals, Inc., for PYLARIFY® (piflufolastat F 18) Injections.
BACKGROUND AND DESCRIPTION: This procurement is for the continued providing of unit dose syringes of F-18 Piflufolastat (Pylarify) for positron emitting tomography (PET) imaging as ordered by the Nuclear Medicine Department.
Pylarify is a radiopharmaceutical, or medicinal radio-compound, and contains radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents to diagnose specific pathologies, such as cancer, osteomyelitis, cardiac ischemia, and infection.
NAICS: 325412 Pharmaceutical Preparation Manufacturing, $34 Million
PSC: 6505 Drugs and Biologicals
AUTHORITY: This procurement will be issued under the authority of FAR Part 8 Required Sources of Supplies and Services. A determination by the Government not to compete this proposed award upon response to this notice is solely within the discretion of the Contracting Officer.
INTERESTED PARTIES: THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTES. Interested parties may identify their interest and capability to respond to this requirement as described in the attached Statement of Work no later than 3:00 PM Mountain Standard Time, Wednesday, February 4th, 2026. Information received in response to this notice must clearly demonstrate the capability of meeting the Government s need as stated above. Include any relevant information (specifications, cut sheets, brochures, capability statement, etc.) confirming the ability to supply the products and/or any services outlined in this notice. Responses to this notice are to be sent to heather.chase2@va.gov.
A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. The Government is not responsible for any potential costs incurred from interested parties desiring to respond to this notice.
ATTACHED: Statement of Work
Attachments/Links
Contracting Office Address
- 6162 S WILLOW DR SUITE 300
- Greenwood Village , CO 80111
- USA
Primary Point of Contact
- Heather Chase
- heather.chase2@va.gov
- Phone Number 303-712-5772
Secondary Point of Contact
- Jan 27, 2026 02:16 pm MSTSpecial Notice (Original)
Get Government Bids Like This by Email
Receive daily bid alerts that match your keywords, business categories, and target regions.
See Also
Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 9/18/2026
Follow 65--SURVIVAL KIT,INDIVIDUA Active Contract Opportunity Notice ID SPE2DS26T414R Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Due by 9/15/2026
Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.
VETERANS AFFAIRS, DEPARTMENT OF
Due by 9/17/2026
* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.